![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00392-012-0416-6/MediaObjects/392_2012_416_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00392-012-0416-6/MediaObjects/392_2012_416_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00392-012-0416-6/MediaObjects/392_2012_416_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00392-012-0416-6/MediaObjects/392_2012_416_Fig4_HTML.jpg)
References
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, For the PROTECT AF Investigators (2009) Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374:534–542
Buttenschoen K, Buttenschoen DC, Odermath R, Beger HG (2001) Diverticular disease-associated hemorrhage in the elderly. Langenbecks Arch Surg 386:8–16
Hansen ML, Sørensen R, Clausen MT, Fog-Petersen ML, Raunsø J, Gadsbøll N, Gislason GH, Folke F, Andersen SS, Schramm TK, Abildstrøm SZ, Poulsen HE, Køber L, Torp-Pedersen C (2010) Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med 170:1433–1441
The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) (2010) Guidelines for the management of atrial fibrillation. Eur Heart J 31:2369–2429
Lam YY, Ma TK, Yan BP (2011) Alternatives to chronic warfarin therapy for the prevention of stroke in patients with atrial fibrillation. Int J Cardiology 150:4–11
Cruz-Gonzalez I, Yan BP, Lam YY (2010) Left atrial appendage exclusion: state of the art. Cath Cardiovasc Interv 75:806–813
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, The RE-LY Steering Committee and Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. New Engl J Med 361:1139–1151
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KAA, Califf RM, The ROCKET AF Steering Committee, for the ROCKET AF Investigators (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New Engl J Med 365:883–891
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, ARISTOTLE Committees and Investigators (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992
Altiok E, Becker M, Hamada S, Reith S, Marx N, Hoffmann R (2011) Optimized guidance of percutaneous edge-to-edge repair of the mitral valve using real-time 3-D transesophageal echocardiography. Clin Res Cardiol 100:675–681
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jabs, A., Hink, U., Warnholtz, A. et al. Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation. Clin Res Cardiol 101, 393–396 (2012). https://doi.org/10.1007/s00392-012-0416-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-012-0416-6